Literature DB >> 11069785

Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection.

M N Dohn1, M L White, E M Vigdorth, C Ralph Buncher, V S Hertzberg, R P Baughman, A George Smulian, P D Walzer.   

Abstract

To detect whether there was geographic clustering of Pneumocystis carinii pneumonia cases among patients with human immunodeficiency virus (HIV) infection, we performed a retrospective analysis of a clinical database. The rates of pneumocystosis were analyzed by zip code zones for evidence of geographical clustering. During the study period, 118 patients at our AIDS Treatment Center had a first episode of P. carinii pneumonia. An analysis of the 24 zip code zones for which a P. carinii pneumonia rate was calculated (requiring a denominator of at least 10 known HIV- infected individuals residing in that zone) showed a trend toward geographic clustering (p = 0.07); when all 45 Cincinnati zip code zones were included in the analysis, clustering of cases was observed (p = 0. 02). By contrast, no clustering was observed for 52 HIV-infected control subjects with respiratory disease or for 960 HIV-infected patients treated at our center during the same time period. These data raise intriguing questions about exposure to exogenous sources of P. carinii and suggest the need for prospective studies.

Entities:  

Mesh:

Year:  2000        PMID: 11069785     DOI: 10.1164/ajrccm.162.5.9707101

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Modeling of spatially referenced environmental and meteorological factors influencing the probability of Listeria species isolation from natural environments.

Authors:  R Ivanek; Y T Gröhn; M T Wells; A J Lembo; B D Sauders; M Wiedmann
Journal:  Appl Environ Microbiol       Date:  2009-07-31       Impact factor: 4.792

2.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 3.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

Review 4.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Authors:  R F Miller; A R Lindley; A Copas; H E Ambrose; R J O Davies; A E Wakefield
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients.

Authors:  Kpandja Djawe; Linda Levin; Alexandra Swartzman; Serena Fong; Brenna Roth; Anuradha Subramanian; Katherine Grieco; Leah Jarlsberg; Robert F Miller; Laurence Huang; Peter D Walzer
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

Review 7.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

8.  On the use of ZIP codes and ZIP code tabulation areas (ZCTAs) for the spatial analysis of epidemiological data.

Authors:  Tony H Grubesic; Timothy C Matisziw
Journal:  Int J Health Geogr       Date:  2006-12-13       Impact factor: 3.918

Review 9.  Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?

Authors:  Alexandre Alanio; Stéphane Bretagne
Journal:  F1000Res       Date:  2017-05-23

Review 10.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.